Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sureda

Showing results (201-210 of 249) with videos related to

Pageof 25
Sort By:
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Prognostic indexes in follicular lymphoma: a comparison of different prognostic systemsG Perea, A Altés, S Montoto, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Bone Marrow Transplantation|March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015A Sureda, P Bader, S Cesaro, et al.
Leukemia|February 20, 2004
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myelomaR García-Sanz, J R González-Porras, J M Hernández, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceJ Rodríguez, M D Caballero, A Gutiérrez, et al.
Bone Marrow Transplantation|January 9, 1998
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phaseD Gallardo, J García-López, A Sureda, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Leukemia|July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry studyS Montoto, C Canals, A Z S Rohatiner, et al.
Bone Marrow Transplantation|February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaI Avivi, C Canals, J-P Vernant, et al.
Pageof 25

Showing results (201-210 of 249) with videos related to

Sort By:
Pageof 25
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Prognostic indexes in follicular lymphoma: a comparison of different prognostic systemsG Perea, A Altés, S Montoto, et al.
Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.
Bone Marrow Transplantation|March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015A Sureda, P Bader, S Cesaro, et al.
Leukemia|February 20, 2004
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myelomaR García-Sanz, J R González-Porras, J M Hernández, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceJ Rodríguez, M D Caballero, A Gutiérrez, et al.
Bone Marrow Transplantation|January 9, 1998
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phaseD Gallardo, J García-López, A Sureda, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Leukemia|July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry studyS Montoto, C Canals, A Z S Rohatiner, et al.
Bone Marrow Transplantation|February 11, 2014
Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphomaI Avivi, C Canals, J-P Vernant, et al.
Pageof 25